Insider trading

Period: 120 months Stock: AGIO Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

35 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

35 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

35 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

35 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
35 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
35 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

35 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Nov 2024
Burns James William Chief Legal Officer
Sold on a plan 2×
$1.14M 21,752 at 52.21
58.1%
Sold half or more
27 Feb 2024
Sold at will 2×
$2.40M 69,329 at 34.67
36.1%
Not planned
23 Feb 2024
Sold at will
$1.58M 47,731 at 33.05
28.0%
Not planned
18 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$2.91M 48,493 at 60.11
75.8%
Sold half or more
10 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$1.25M 20,853 at 60.06
57.4%
Sold half or more
4 Feb 2020
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$2.49M 49,638 at 50.08
96.8%
Sold half or more
13 Nov 2019
FOUSE JACQUALYN A Chief Executive Officer
Bought
$1.25M 40,322 at 31.00
×29
First buy on file
12 Nov 2019
CELGENE CORP /DE/ 10% owner
Bought
$12.50M 403,225 at 31.00
29.3%
First buy on file
12 Sep 2018
MARAGANORE JOHN Director
Sold, plan not stated
$1.02M 14,162 at 71.74
39.1%
1 Jun 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 4×
$1.24M 13,000 at 95.35
100%
Sold half or more
30 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated
$4.11M 45,626 at 90.07
100%
Sold half or more
23 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$4.46M 49,374 at 90.40
100%
Sold half or more
23 May 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated
$1.37M 15,177 at 90.00
21.0%
1 May 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$1.08M 13,000 at 83.04
100%
Sold half or more
2 Apr 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 5×
$1.01M 13,000 at 77.72
100%
Sold half or more
1 Mar 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.05M 13,000 at 81.09
100%
Sold half or more
1 Feb 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.02M 13,000 at 78.75
100%
Sold half or more
26 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 3×
$1.91M 23,572 at 81.09
100%
Sold half or more
24 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 2×
$1.08M 13,553 at 80.01
100%
Sold half or more
23 Jan 2018
CELGENE CORP /DE/ 10% owner
Bought
$57.03M 851,154 at 67.00
163%
First buy on file
23 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated
$2.63M 32,875 at 80.01
100%
Sold half or more
23 Jan 2018
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$1.87M 25,000 at 74.83
100%
Sold half or more
16 Jan 2018
Schenkein David P Chief Executive Officer
Sold, plan not stated 4×
$3.88M 53,000 at 73.16
100%
Sold half or more
4 Oct 2017
Schenkein David P Chief Executive Officer
Sold, plan not stated
$5.61M 80,000 at 70.14
100%
Sold half or more
18 Sep 2017
Schenkein David P Chief Executive Officer
Sold, plan not stated
$2.35M 35,000 at 67.12
100%
Sold half or more
2 Aug 2017
Schenkein David P Chief Executive Officer
Sold, plan not stated
$1.45M 24,000 at 60.55
100%
Sold half or more
2 Aug 2017
Biller Scott Chief Scientific Officer · indirect
Sold, plan not stated
$1.26M 21,000 at 60.06
45.2%
24 Apr 2017
Celgene European Investment Co LLC 10% owner · indirect
Bought
$30.92M 624,575 at 49.50
50.7%
First buy on file
3 Mar 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 3×
$2.06M 40,559 at 50.85
99.9%
Sold half or more
28 Feb 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 2×
$2.38M 47,859 at 49.77
54.1%
Sold half or more
27 Feb 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 3×
$9.62M 195,223 at 49.26
68.8%
Sold half or more
23 Feb 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 2×
$2.44M 50,996 at 47.90
15.2%
22 Feb 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 2×
$2.39M 47,938 at 49.91
12.5%
21 Feb 2017
NELSEN ROBERT Director · indirect
Sold, plan not stated 2×
$1.85M 36,430 at 50.73
8.7%
14 Nov 2016
Biller Scott Chief Scientific Officer
Sold, plan not stated
$1.79M 27,500 at 65.00
36.3%
Showing 1–35 of 35.